bf/NASDAQ:CMPS_icon.jpeg

NASDAQ:CMPS

COMPASS Pathways plc

  • Stock

4.10

+3.02%

−0.12

USD last updated 13/08 01:59:42

Last Close

4.22

12/08 22:23

Market Cap

451.06M

Beta: 2.51

Volume Today

708.59K

Avg: 279.39K

PE Ratio

−4.64

PFCF: −5.88

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as C...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1.2-1-0.8-0.6-0.4-0.22019-03-302019-12-312021-05-132023-02-282024-05-082025-05-06

    Revenue (Estimate*)

    1M2M3M4M2019-03-302019-12-312021-05-132023-02-282024-05-082025-05-06

    *Estimate based on analyst consensus